Scarica l'app Stockscreener
8.73
1.47%
-0.13
Precedente Chiudi:
$8.86
Aprire:
$8.8
Volume 24 ore:
9,463
Relative Volume:
0.08
Capitalizzazione di mercato:
$557.45M
Reddito:
-
Utile/perdita netta:
$-159.39M
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
$-105.22M
1 W Prestazione:
-12.35%
1M Prestazione:
-16.86%
6M Prestazione:
-38.99%
1 anno Prestazione:
-17.87%
Intervallo 1D:
$8.69
$8.80
Intervallo di 1 settimana:
$8.69
$9.79
Portata 52W:
$8.69
$17.02
Abivax Adr Stock (ABVX) Company Profile
Confronta ABVX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ABVX | 8.73 | 557.45M | 0 | -159.39M | -105.22M | 0.00 |
| VRTX | 445.32 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 736.78 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 584.00 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.00 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.17 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-14 | Iniziato | Leerink Partners | Outperform |
| 2023-11-14 | Iniziato | Morgan Stanley | Equal-Weight |
Abivax Adr Borsa (ABVX) Ultime notizie
Abivax Initiates $150 Million ATM Program on Nasdaq - TipRanks
Abivax Reports Strong Q3 Financials and Clinical Progress - TipRanks
Check Out Abivax ADR (ABVX)’s Trade Data Rather Than the Analysts’ Views - SETE News
Insider’s View: Deciphering Abivax ADR (ABVX)’s Financial Health Through Ratios - The Dwinnex
Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation - GlobeNewswire Inc.
Abivax SA Unveils New Ulcerative Colitis Treatment Data - TipRanks
Abivax Reports Progress in Ulcerative Colitis Therapy - TipRanks
DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law - GlobeNewswire
Wall Street Analysts Believe Abivax SA Sponsored ADR (ABVX) Could Rally 193.62%: Here's is How to Trade - MSN
Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Abivax SA Details Financial Struggles and Advances - TipRanks
Abivax SA Reveals Soaring R&D Costs in H1 2024 - TipRanks
Inflammatory Bowel Disease Treatment Market Size Expected to Reach USD 33.19 Bn by 2032 - GlobeNewswire Inc.
Abivax SA Advances with Positive Trial OutcomesTipRanks.com - TipRanks
Abivax SA Announces Upcoming General MeetingTipRanks.com - TipRanks
Guggenheim starts Abivax stock with Buy, cites promising ulcerative colitis drug By Investing.com - Investing.com
Abivax SA Secures Funding and Expands Operations - TipRanks
Citi Appointed as Depositary Bank for Abivax SA's ADR Program - Business Wire
Abivax Adr Azioni (ABVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):